Patents by Inventor Yanxin YIN

Yanxin YIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240094418
    Abstract: The present invention provides a selection method of array length of observation system, comprising: step S101: obtaining a seismic response equation for any point on ground based on wavefield propagation theory; step S102: determining at least one selection criterion of an optimum array length considering different factors according to the seismic response equation; step S103: obtaining the array lengths considering the different factors respectively according to the at least one selection criterion of the optimum array length; and step S104: integrating the array lengths considering the different factors and determining that the optimum array length is ?{square root over (2)} times the depth of the destination layer. Compared with conventional array length calculation method the demonstration method of array length as proposed in the present invention has the advantages of higher accuracy and applicability for destination layers.
    Type: Application
    Filed: June 16, 2022
    Publication date: March 21, 2024
    Inventors: Huaishan LIU, Mingxin ZHAO, Yuzhao LIN, Linfei WANG, Lei XING, Yanxin YIN
  • Patent number: 11634496
    Abstract: A method for treating or preventing vascular endothelial cell injured diseases, especially cerebral infarctions or myocardial infarctions, by administering a c-MET agonist antibody to a subject in need thereof, and specific c-MET agonist antibodies.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: April 25, 2023
    Assignee: TONGJI UNIVERSITY SUZHOU INSTITUTE BIOMEDICAL RESEARCH CENTER
    Inventors: Jianmin Fang, Ming Jiang, Yanxin Yin, Jia Guo, Lihua Yu
  • Publication number: 20210087277
    Abstract: A method for treating or preventing vascular endothelial cell injured diseases, especially cerebral infarctions or myocardial infarctions, by administering a c-MET agonist antibody to a subject in need thereof, and specific c-MET agonist antibodies.
    Type: Application
    Filed: October 31, 2018
    Publication date: March 25, 2021
    Inventors: Jianmin FANG, Ming JIANG, Yanxin YIN, Jia GUO, Lihua YU
  • Publication number: 20200190210
    Abstract: Use of the extracellular loop 1 (ECL 1) of TM4SF1 as a target for cancer treatment. More specifically, specific binding of antibodies of the ECL1 of TM4SF1 and peptides of ECL1.
    Type: Application
    Filed: September 12, 2018
    Publication date: June 18, 2020
    Inventors: Jianmin FANG, Hua GAO, Guang CHEN, Yanxin YIN, Jia GUO